Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16897039 | 1.00 | ALDH1A1 (0.52) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL6440117 | 0.98 | ALDH1A1 (0.50) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL3100777 | 0.98 | ALDH1A1 (0.50) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL368279 | 0.98 | ALDH1A1 (0.50) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL12559649 | 0.98 | ALDH1A1 (0.50) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL6446922 | 0.98 | ALDH1A1 (0.50) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL979078 | 0.92 | ALDH1A1 (0.54) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL16897049 | 0.92 | ALDH1A1 (0.54) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL16896971 | 0.92 | ALDH1A1 (0.54) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL1099616 | 0.92 | ALDH1A1 (0.52) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3558903-B1 | PROCESS FOR PHOSPHORYLATING A COMPLEX ALCOHOL | AVECHO BIOTECHNOLOGY LTD (AU) | 2024-07-03 | — | — | EP | disclosed |
| WO-2023223888-A1 | METHOD FOR PRODUCING POLYCARBONATE RESIN, AND ALICYCLIC POLYCARBONATE RESIN | 旭化成株式会社 | 2023-11-23 | — | — | WO | disclosed |
| US-11753435-B2 | Process | AVECHO BIOTECHNOLOGY LIMITED (AU) | 2023-09-12 | — | — | US | disclosed |
| US-20220106353-A1 | PROCESS | AVECHO BIOTECHNOLOGY LIMITED (AU) | 2022-04-07 | — | — | US | disclosed |
| US-20220066347-A1 | LIQUID ELECTROPHOTOGRAPHIC INK COMPOSITIONS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-03-03 | — | — | US | disclosed |
| EP-3914657-A1 | LIQUID ELECTROPHOTOGRAPHIC INK COMPOSITIONS | Hewlett-Packard Development Company, L.P. (US) | 2021-12-01 | — | — | EP | disclosed |
| CN-109721723-B | Surfactant, method for producing the same, and solution containing the same | 中日合成化学股份有限公司 | 2021-07-06 | — | — | CN | disclosed |
| WO-2021071504-A1 | LIQUID ELECTROPHOTOGRAPHIC INK COMPOSITIONS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2021-04-15 | — | — | WO | disclosed |
| CN-110662733-A | Method of producing a composite material | 埃维科生物技术有限公司 | 2020-01-07 | — | — | CN | disclosed |
| US-20190330260-A1 | PROCESS | AVECHO BIOTECHNOLOGY LIMITED (AU) | 2019-10-31 | — | — | US | disclosed |
| US-5559109-A | Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist | SANKKO COMPANY, LIMITED (JP) | 1996-09-24 | — | — | US | disclosed |
| US-5556852-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | SANKYO COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0395446-B1 | N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists | SANKYO CO (JP) | 1995-03-01 | — | — | EP | disclosed |
| US-5369106-A | N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists | SANKYO COMPANY, LIMITED (JP) | 1994-11-29 | — | — | US | disclosed |
| US-5248538-A | SULFONAMIDO OR AMIDO SUBSTITUTED PHTHALOCYANINES FOR OPTICAL RECORDING | EASTMAN KODAK COMPANY (US) | 1993-09-28 | — | — | US | disclosed |
| US-5192766-A | Platelet activating factor antagonist | SANKYO COMPANY, LIMITED (JP) | 1993-03-09 | — | — | US | disclosed |
| EP-0519395-A1 | Sulfonamido or amido substituted phthalocyanines for optical recording | EASTMAN KODAK COMPANY (US) | 1992-12-23 | — | — | EP | disclosed |
| WO-1991018905-A1 | RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY | SANKYO COMPANY LIMITED (JP) | 1991-12-12 | — | — | WO | disclosed |
| EP-0460950-A1 | Radicicol derivatives, their preparation and their anti-tumour activity | Sankyo Company Limited (JP) | 1991-12-11 | — | — | EP | disclosed |
| EP-0395446-A2 | N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists | Sankyo Company Limited (JP) | 1990-10-31 | — | — | EP | disclosed |